Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the diagnosis of venous thromboembolism in emergency department by Mullier, François et al.
RESEARCH OUTPUTS / RÉSULTATS DE RECHERCHE
Author(s) - Auteur(s) :
Publication date - Date de publication :
Permanent link - Permalien :
Rights / License - Licence de droit d’auteur :
Bibliothèque Universitaire Moretus Plantin
Institutional Repository - Research Portal
Dépôt Institutionnel - Portail de la Recherche
researchportal.unamur.be
Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the
diagnosis of venous thromboembolism in emergency department
Mullier, François; Vanpee, Dominique; Jamart, Jacques; Dubuc, Eric; Bailly, Nicolas; Douxfils,
Jonathan; Chatelain, Christian; Dogné, Jean Michel; Chatelain, Bernard
Published in:
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
DOI:
10.1097/MBC.0000000000000020
Publication date:
2014
Document Version
Early version, also known as pre-print
Link to publication
Citation for pulished version (HARVARD):
Mullier, F, Vanpee, D, Jamart, J, Dubuc, E, Bailly, N, Douxfils, J, Chatelain, C, Dogné, JM & Chatelain, B 2014,
'Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the diagnosis of venous
thromboembolism in emergency department' Blood coagulation & fibrinolysis : an international journal in
haemostasis and thrombosis, vol. 25, no. 4, pp. 309-315. https://doi.org/10.1097/MBC.0000000000000020
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 21. May. 2019
CE: Namrta; MBC/052071; Total nos of Pages: 7;
MBC 052071
Original article 1Comparison of five D-dimer reagents and application of an
age-adjusted cut-off for the diagnosis of venous
thromboembolism in emergency department
Franc¸ois Mulliera,b,c, Dominique Vanpeed, Jacques Jamarte, Eric Dubuca,
Nicolas Baillya, Jonathan Douxfilsb, Christian Chatelainc,f, Jean-Michel Dogne´b,c
and Bernard Chatelaina,cThere is still a considerable uncertainty concerning D-dimer
cut-off values used in exclusion of venous thromboembolic
(venous thromboembolism, VTE) disease, especially among
the elderly patients. The objectives were to compare five
different D-dimer reagents in the daily practice of an
emergency department and to test retrospectively the
performances of an age-adjusted cut-off. A total of 473
consecutive ambulatory outpatients suspected of VTE
(confirmed VTEU21) were included in this study. Five
commercially available tests were assessed: STA-Liatest
D-Di (LI), AxSYM-D-Dimer (AX), VIDAS D-Dimer (VI),
INNOVANCE D-Dimer (IN), and HemosIL D-Dimer HS (HS).
When using a cut-off value of 500ng/ml fibrinogen equivalent
units (FEUs), D-dimer reagents differ in their abilities to avoid
further testing. Indeed, LI allowed exclusion of VTE diagnosis
in statistically more patients than VI, AX, and IN but not HS.
The use of an age-adjusted cut-off is cost-effective without
increasing significantly the number of false negative results.
The interest of such strategy is more or less pronounced,
depending on the type of D-dimer reagent. The application ofCopyright © Lippincott Williams & Wilkins. Unaut
0957-5235  2013 Wolters Kluwer Health | Lippincott Williams & Wilkinsan age-adjusted cut-off may be useful to reduce differences
among D-dimer reagents to lower costly imaging studies.
Prospective validation studies on large cohorts of patients are
required to determine the safety of such strategy. Blood
Coagul Fibrinolysis 24:000–000  2013 Wolters Kluwer
Health | Lippincott Williams & Wilkins.
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Clinical prediction models such as Wells pretest
probability (PTP) have improved diagnostic accuracy
of venous thromboembolism (VTE) [1]. The combi-
nation of a low PTP and a negative D-dimer has an
extremely high negative predictive value (NPV) for
VTE [1]. However, the knowledge of an abnormal D-
dimer test before clinical examination leads to a higher
clinical decision rule score [2]. This demonstrates that
decision rules remain very subjective in spite of all efforts
to improve clinical objectivity, and that they need to be
complemented by the use of objective measures like
D-dimer performed after clinical scoring. The high pre-
valence of VTE makes D-dimer assay an important
diagnostic tool in daily clinical practice. Nevertheless,
D-dimer standardization is still difficult as it concerns the
detection in a complex mixture of fibrin degradation
products of different sizes [1,3,4]. In addition, differences
in D-dimer assays exist, which may complicate the
interpretation of the results. Indeed, antibodies used in
D-dimer assays react with cross-linked fibrin in general,
including fibrin oligomers of variable size without prior
proteolysis by plasmin [1,5]. Consequently, despite
proposed models for the harmonization of test resultsand improvement of between-center variation, there
is still a lack of agreement of cut-off values between
different assays [1,6–8]. The age of the patient is one of
the main factors leading to this uncertainty. The clinical
strategy for ruling out VTE is unclear in elderly patients
as both D-dimer concentration and VTE prevalence
increase with age [1,9]. Douma et al. [9] proposed cut-
off values adjusted to age combined with clinical
probability to improve the utility of the D-dimer test
for the exclusion of VTE among older patients without
reducing the safety.
These variations between D-dimer assays and the
importance of age in cut-off uncertainty led us to conduct
a comparison study of classical D-dimer reagents in the
daily practice of an emergency department and to assess
the age-adjusted cut-off point proposed by Douma et al.
[9] on a large panel of reagents.
Materials and methods
Study design
Study population
This study initially included 473 consecutive unselected
ambulatory outpatients with clinically suspected deephorized reproduction of this article is prohibited.
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In order to be in conformity with the daily practice
of an emergency department, patients and emergency
physicians were blinded to the ongoing study and to
D-dimer results except for the VIDAS D-dimer result
(BioMe´rieux, Craponne, France), which is the reagent
currently used in routine in our laboratory.
The study was divided in two parts. The first part con-
sisted of a prospective assessment of the strategy using
standard cut-off of 500 ng/ml for five D-dimer reagents,
whereas the second part aimed at retrospectively
evaluating the incremental benefit of using an age-
adjusted cut-off.
Patients were eligible if they had one or more of the
following symptoms: swelling, redness, tenderness, pain
of the lower extremity, edema, labored breathing, cough-
ing, lung-related chest pain, and dyspnea. Patients were
excluded if they were younger than 18 years, pregnant
women, or had received low molecular-weight heparin
(LMWH) or vitamin K antagonists (VKAs) [1].
Data collection
Patients were enrolled 24 h/day, 7 days/week. The assess-
ment of clinical probability of pulmonary embolism
or DVT was performed by one emergency physician
and was based on the Wells scores [10,11]. In case of
low or medium PTP, D-dimer was performed following
international recommendations [1]. In case of positive
VIDAS D-dimer, complete compression ultrasonography
and multidetector spiral computed tomography were
performed for suspected DVT and pulmonary embolism,
respectively. In addition, complete compression ultra-
sonography and ventilation perfusion scintigraphy
were performed for suspected subsegmental pulmonary
embolism based on multidetector spiral computed
tomography.
During 90 days of follow-up, venous thromboembolic
complications and death caused by a possible thrombo-
embolic event were recorded for all patients during
a consultation or by a phone questionnaire (criteria:
presence/absence of VTE, LMWH, or VKA during theopyright © Lippincott Williams & Wilkins. Unauth
Table 1 Baseline characteristics of patients with clinically suspected v
Characteristics
Patients
(N¼430)
Low PTP
(N¼341, 79.
Age (years): mean SD 61þ/18 60þ/18
Female (%) 212 (49.3) 164 (48.2)
Venous thrombosis (% of suspected
VTE, % of suspected DVT)
5 (1.2, 3.9) 1 (0.3, 1.
Pulmonary embolism (% of suspected
VTE, % of suspected PE)
13 (3.0, 4.3) 5 (1.5, 2.
Venous thrombosis and pulmonary
embolism (% of suspected VTE)
3 (0.7) 0 (0)
Lost to follow-up (% of suspected VTE) 10 (2.3) 7 (2.1)
Values are numbers (percentages) of patients unless specified otherwise. Data are prese
(PTP). DVT, deep vein thrombosis; PE, pulmonary embolism; VTE, venous thromboempast 3 months). All clinical data were revised inde-
pendently by two emergency physicians. The study
was approved by the local ethical committee on human
research.
Samples
The D-dimer analysis was performed on platelet-poor
plasma (PPP). PPP was obtained after centrifugation
during 15min at 2080g at room temperature on a
109mmol/l citrate Venosafe (Terumo Europe, Leuven,
Belgium) whole blood sample.
Five different commercially available tests were assessed
on the same PPP. STA-Liatest DDi (LI) (Diagnostica
Stago, Asnie`res sur Seine, France), AxSYM D-Dimer
(AX) (Abbott, Wiesbaden, Germany), and the VIDAS
D-Dimer (VI) (BioMe´rieux) were performed on fresh
samples within 3 h after sampling. STA-R Evolution,
Abbott AxSYM, and BioMe´rieux mini VIDAS were used
as instruments, respectively. INNOVANCE D-Dimer
(IN) (Siemens, Marburg, Germany) and HemosIL
D-Dimer HS (HS) (Instrumentation Laboratory,
Bedford, Massachusetts, USA) were performed after
freezing at 808C and thawing during 5min at 378C.
BCS coagulation analyzer and ACL-TOP were used as
instruments, respectively. D-dimer was previously shown
stable after freezing for 36 months at 608C [12]. The
results of LI, AX, VI, and IN are expressed in ng/ml of
fibrinogen equivalent units (FEUs), as these assays use
crude plasmin digested lysates of cross-linked fibrin clots
as calibrators. The calibrator used in the HS consists of
purified D-dimer fragments obtained from a plasmin-
digested clot. The results of this assay are, therefore,
expressed in ng/ml of D-dimer units. Results of HS
were mathematically transformed by the ACL-TOP
software (Instrumentation Laboratory) in ng/ml of
FEU. The standard cut-off was, therefore, 500 ng/ml of
FEU for all the D-dimer assays.
Data analysis
Patients were classified according to the Wells score in
low, medium, or high PTP (Table 1). The correlation
between VI and the four other D-dimer tests was assessedorized reproduction of this article is prohibited.
enous thromboembolism
3%)
Medium PTP
(N¼59, 13.7%)
High PTP
(N¼3, 0.7%)
Not determined PTP
(N¼27, 6.3%)
66þ/16 49þ/11 61þ/14
30 (50.8) 2 (66.7) 15 (55.6)
1) 2 (3.4, 14.3) 0 (0, 0) 2 (7.4, 8.0)
0) 7 (11.9, 15.6) 1 (33.3, 100) 0 (0, 0)
1 (1.7) 1 (33.3) 1 (3.7)
1 (1.7) 0 (0) 2 (7.4)
nted for all patients and after subdivision in low, medium, or high pretest probability
bolism.
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D-dimer in emergency department Mullier et al. 3by Pearson coefficient. Paired t-test and Bland–Altman
test were performed to compare mean D-dimer values
for VI and LI above their quantification limit (45 and
220 ng/ml, respectively). Comparison of the five D-dimer
tests was then performed for patients with low or medium
clinical probability of VTE (n¼ 400 for VI, LI, and AX,
but only 382 for IN and 385 for HS due to insufficient
sample).
Results of each test were dichotomized with either
500 ng/ml or an age-adjusted cut-off calculated as follows:
[(age 10) (ng/ml) (if age is higher than 50 years)], as
cut-off for all D-dimer reagents [9].
The sensitivity, specificity, NPV, and the number
needed to test (NNT) [1] by D-dimer to rule out
one VTE were then calculated with their exact 95%
confidence intervals (CIs) based on F distribution.
The NNT was defined as the number of patients
in whom D-dimer must be measured to rule out one
DVT or one pulmonary embolism. Binomial and x2 tests
were used to compare proportions. Lost to follow-up
was considered negative or excluded for the statisticalCopyright © Lippincott Williams & Wilkins. Unaut
Fig. 1
473 outpatien
suspected
430 patie
include
403 patie
Wells ru
400 patients
Score low-
intermediate
145 patients
VI negative
258 patient
3-month follow-up
0 patients with VTE
Study flow chart. CDR, clinical decision rule; DVT, deep vein thrombosis; P
thromboembolism; y, years.analysis. The analysis with lost to follow-up considered as
positive was not shown as the 3-month thromboembolic
risk in patients left untreated after normal proximal
compression ultrasonography was 0.6% (95% CI: 0.4–
0.9%), as reported in a review by Righini et al. [13].
Statistical analysis was performed by SPSS 15.0
(SPSS Inc., Chicago, Illinois, USA), SC (Lambda-Plus,
Gembloux, Belgium), andMedcalc (version 10.4.8; Gent,
Belgium) statistical softwares.
Results
Patient characteristics
Of the 473 patients, three were less than 18 years and
40 received acenocoumarol at the time of inclusion.
The data from the remaining 430 patients (91%) were
used for our analysis (Fig. 1). Baseline characteristics of
these patients are described in Table 1. Ten patients
(2.3%) had negative imaging studies at the initial visit,
but the follow-up at 3 months was not possible.
Such patients were considered negative or excluded
for the statistical analysis.horized reproduction of this article is prohibited.
ts with
 VTE
nts
d
43 patients excluded
3 age < 18y
40 use of oral anticoagulation
27 patients: No CDR
(2 DVT, 1 DVT+PE, 2 doubts)
nts
le
3 patients
Score high
s score high or VI positive
3-month follow-up
18 (7.0%) patients
with VTE
E, pulmonary embolism; VI, VIDAS D-dimer; VTE, venous
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4 Blood Coagulation and Fibrinolysis 2013, Vol 00 No 00A total of 218 men and 212 women aged from 18 to
97 years (mean: 61 years, median: 63 years) were included
in this study. The number of patients suspected
of pulmonary embolism and DVT were 302 and 128,
respectively. Three hundred thirteen patients (72.8%)
were aged 50 years and older [165 men (52.7%), 148
women (47.3%)].
As shown in Table 1, 21 out of the 430 patients (4.9%)
included in the study had DVT and/or pulmonary embo-
lism. All DVT (n¼ 8) were proximal [14]. All pulmonary
embolisms were nonsubsegmental. The patients were
classified as having low (N¼ 341/79.3%), medium
(N¼ 59/13.7%), and high PTP for VTE (N¼ 3/0.7%).
The PTP was not determined for 27 patients (6.3%).
Correlation between D-dimer assays
In comparison with the currently used D-dimer in the
daily practice (VI), Pearson correlation coefficients for LI,
AX, IN, and HS were 0.938, 0.965, 0.894, and 0.907,
respectively (P< 0.001).
Comparison with clinical data
Lost to follow-up considered negative
With the cut-off value of 500 ng/ml, the VI was normal
in 145 of 400 patients with a low or medium probability
of VTE (36.2%), and no patient developed VTE during
the initial investigation or the 3-month follow-up
(0%, 95% CI: 0 to 2.5%; Tables 2 and 3). The sensitivity,
specificity, and NPV were 100.0% (95% CI: 100.0–
100.0%), 37.8% (95% CI: 32.9–42.8%), and 100.0%
(95% CI: 100.0–100.0%), respectively. The NNT to rule
out one VTE was 2.8.
Using the age-adjusted cut-off value, D-dimer test
results were negative in 50% of the patients (200/400,
NNT¼ 2.0) (Tables 2 and 3). This resulted in 13.8%opyright © Lippincott Williams & Wilkins. Unauth
Table 2 Comparison of VIDASD-dimerwith clinical outcome (presence o
clinical probability (based on Wells clinical decision rule)
(A)
Cut-off: 500 ng/ml
VTE
VI Above 16
Below 0
Total 16
(B)
Age-adjusted cut-off
VTE
VI Above 15
Below 1
Total 16
True positive, false positive, true negative, and false negative were shown according to a
was considered negative for the statistical analysis. N¼400 [All patients (n¼430) m
probability (n¼27)]. VI, VIDAS D-dimer; VTE, venous thromboembolism.absolute increase in the number of patients in whom
D-dimer levels were considered normal. The sensitivity,
specificity, and NPV were 93.8% (95% CI: 69.7–99.0),
51.8% (95% CI: 46.7–56.9%), and 99.5% (95% CI: 97.2–
100.0), respectively. Of these 200 patients, one
developed pulmonary embolism during investigation
(0.5%, 95% CI: 0–2.8%). VI, LI, AX, IN, and HS for
this 86-year-old patient with a medium PTP were 659,
590, 789, 1170, and 719 ng/ml, respectively.
Using either 500 ng/ml or the age-adjusted cut-off as the
cut-off value, the NPV and sensitivity (Table 3) were not
statistically significant between the five D-dimer tests.
However, the number of patients with results below the
cut-off and specificity were statistically different. Indeed,
with the standard cut-off of 500 ng/ml, the proportion
of positive results was significantly lower for LI, AX, and
HS than for VI (P<0.001, P¼ 0.016, and P<0.001,
respectively). The proportion did not differ significantly
between IN and VI (P¼ 0.184). The number of patients
with results below the cut-off for VI, LI, AX, IN, and HS
were 145 (36.2%, 95% CI: 31.5–41.2%), 204 (51.0%,
95% CI: 46.0–56.0%), 152 (38.0%, 95% CI: 33.2–
43.0%), 147 (38.5%, 95% CI: 33.6–43.6%), and 174
(45.2%, 95% CI: 40.1–50.3%), respectively.
Thus, LI allowed exclusion of VTE diagnosis in statisti-
cally more patients than VI, AX, and IN (x2 P:<0.0005,
P<0.0005 and P¼ 0.0006, respectively).
Below 1000 ng/ml for VI (n¼ 185), mean LI is signifi-
cantly lower than mean VI (paired Student’s t-test
P: 0.0074) with a mean difference [(LIVI)/(LI/2 þ
VI/2)] 100 of 18.5% (Bland–Altman plot) (Fig. 2).
With the age-adjusted cut-off value, the differences are
less pronounced between the D-dimer reagents. Indeed,
only the proportion of positive results for LI and HSorized reproduction of this article is prohibited.
r absence of venous thromboembolism) for patients with a nonhigh
Clinical outcome Total
No VTE
239 255
145 145
384 400
Clinical outcome Total
No VTE
185 200
199 200
384 400
cut-off value of 500 ng/ml (A) or an age-adjusted cut-off value (B). Lost to follow-up
inus patients with a high clinical probability (n¼3) minus patients with no pretest
Copyright © Lippincott Williams & Wilkins. Unaut
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Bland–Altman plot showing D-dimer results below 1000ng/ml for
VIDAS D-dimer (VI; n¼185) and above the quantification limit [VI:
45 ng/ml, STA-Liatest DDi (LI): 220ng/ml]. Mean LI is significantly
lower than mean VI (paired Student’s test P: 0.0074) with a mean
difference [(LIVI)/ (LI/2 þ VI/2)]100 of 18.5%.remains lower than for VI (P< 0.001 and P¼ 0.001,
respectively).
Finally, as shown in Table 3, for VI, LI, AX, IN, and HS,
there was a 13.8, 7.8, 13.2, 9.7, and 10.1% absolute
increase in the number of patients with a nonhigh
probability of VTE and with a negative D-dimer test
result when the age-adjusted cut-off value was used,
respectively.
Lost to follow-up excluded
The results were similar without any modification to
the conclusions (data not shown).
Discussion
The high prevalence of VTE makes D-dimer assay a
very important diagnostic tool in daily clinical practice.
However, 20 years after its first use in the diagnostic
workup of suspected VTE, there is still a lack of
standardization of D-dimer assay values between
different assays due to the complexity of the D-dimer
entity [1]. Differences between D-dimer assays may be
caused by the following parameters: antibody specificity,
time dependence of neo-epitope expression in the course
of fibrin formation and dissolution, assay format, purity or
heterogeneity of the calibrator, possible matrix effects
of plasma on epitope presentation, and interference
by irrelevant (noncross-linked) analytes [5]. These dis-
crepancies between different D-dimer assays as well
as the two different reporting units in use and the
influences of other variables such as age of the patient
have led to a considerable uncertainty concerning the
cut-off values used in exclusion of VTE [1,15–20].horized reproduction of this article is prohibited.
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6 Blood Coagulation and Fibrinolysis 2013, Vol 00 No 00In the present study, we demonstrate that while the five
D-dimer reagents are highly correlated, their abilities to
avoid further testing for diagnosing VTE are statistically
significant. This is due to differences in mean D-dimer
values in the lowD-dimer range (<1000 ng/ml). Although
all D-dimer tests studied in the present work use a cut-off
value of 500 ng/ml (or 500 ng/ml FEU), this apparent
agreement at 500 ng/ml represents harmonization of
values at a single point and it cannot be assumed that
the different assays are in agreement across a wider range
as illustrated in Fig. 2. Furthermore, the use of an age-
adjusted cut-off as suggested by Douma et al. [9] in a
retrospective multicenter study is cost-effective without
increasing significantly the number of false negative,
whatever the D-dimer reagent. Indeed, in our institution,
D-dimer, complete compression ultrasonography, multi-
detector spiral computed tomography, or ventilation
perfusion scintigraphy costs 3.37 s, 39.95 s, 127.77 s,
and 259.76 s during the day, respectively. During the
nights and the week-ends, the cost of a complete
compression ultrasonography reaches 104.56 s. Using
the cut-off of 500 ng/ml, the proportion of positive results
and the specificity were statistically higher for LI, AX,
and HS than for VI. However, the NPV and sensitivity
were not statistically different between assays. LI allowed
exclusion of VTE diagnosis in statistically more patients
than VI, AX, and IN, but not HS. The use of the age-
adjusted cut-off allowed lowering the differences
between the reagents as only the proportion of positive
results for LI and HS remains lower than for VI. This
confirms that discordant D-dimer results of different
quantitative assays are often related to age [15–17].
Our results are in agreement with previously published
studies. The PROLONG study showed the interest of
using different cut-off levels according to age to evaluate
the individual risk of recurrent VTE after cessation of
vitamin K antagonism [21]. Moreover, Haas et al. [16]
previously showed that a cut-off level of 750 ng/ml for
patients at least 60 years improves the clinical perform-
ance of STA-Liatest, Tina-quant (Roche, Mannheim,
Germany), and INNOVANCE in combination with
the PTP score without the loss of NPV. A recent large
retrospective study using HemosIL DDi HS has shown
that in older patients, elevated values (>1000 ng/ml)
are more frequently associated with VTE, so the authors
have also suggested the use of age-adjusted cut-offs [20].
The strengths of our study are the use of five different
D-dimer assays on the same samples and the study design
mimicking the real life of an emergency department.
Limitations
The limitations of our study are the limited sample size;
the low prevalence of VTE in our study (21 cases, 4.9%)
compared with other data reported in the literature [1];
the very low number of high PTP; and the retrospective
application of the age-adjusted formula. The low number
of high PTPmay be explained by the quality of screeningopyright © Lippincott Williams & Wilkins. Unauthof suspected VTE in this population. However, such
low prevalence has already been reported by others
[22] in the daily practice of an emergency department
and is more representative of the real life than the
current literature.
The limited sample size prevents drawing firm con-
clusions from these results as variation of false negative
rate of one or two patients could strongly modify
the results. However, our results have been supported
by recent retrospective studies confirming that the
age-adjusted cut-off increased the clinical usefulness of
D-dimer to exclude VTE in older patients [23–25].
A large prospective study is still needed to assess the
safety and usefulness of the age-adjusted cut-off before
implementation in daily emergency practice.
Conclusion
When using a cut-off value of 500 ng/ml, D-dimer
reagents differ in their abilities to avoid further testing
to exclude VTE. The application of an age-adjusted
cut-off may be useful to reduce differences among
D-dimer reagents and to lower costly imaging studies.
Interestingly, the information of age-adjusted cut-offs may
be automatically included in the laboratory reports, as
enabled by the modern laboratory information systems.
Prospective validation multicenter studies using reagent-
specific values, are now required to determine the safety
of such strategy and to confirm that clinicians can appro-
priately apply this formula in the chaotic emergency
department setting.
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